Self-monitoring of blood glucose in type 2 diabetes: an inter-country comparison.
Self-monitoring of blood glucose (SMBG) in type 2 diabetic patients was compared across 14 countries. There was an unexpectedly high SMBG-use in non-insulin-treated patients. Reimbursement polices differed by country, region, insurance status, and patient income. More rigorous and systematic data collection is needed to ensure evidence-based SMBG-use.
D015190:Blood Glucose Self-Monitoring / Q000706:statistics & numerical data*; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis*; D014943:Global Health; D006801:Humans; D007182:Income; D007349:Insurance, Health, Reimbursement; D038622:Internationality